Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin for Adolescent Migraine Prevention Study (The MAP Study).

NCT03150797 is registered in ClinicalTrials.gov with Amy Gelfand as lead sponsor.

NCT NCT03150797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03150797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin for Adolescent Migraine Prevention Study (The MAP Study).
Lead sponsor
Amy Gelfand
Phase
Phase 2
Overall status
Terminated
Start date
August 2, 2017
Completion date
December 1, 2019
Enrollment
72 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine